Comparision of Intravaginal with Interstitial Brachytherapy in Cervical Cancer after Inadvertent Hysterectomy: A Retrospective Study

Author:

Choudhary Sunil1,Pandey Ankita2,Singh Ankita1,Mourya Ankur3,Gupta Neha4,Shajid Syed Mohamed5,Venkatachalam Gogul Priean1,Rai Sangita1,Agarwal Sakshi1,Venkatraman Pitchaikannu1,Aggarwal Lalit Mohan1

Affiliation:

1. Banaras Hindu University

2. Postgraduate Institute of Medical Education & Research

3. Cancer Hospital, N.S.C.B Medical College

4. Apex Hospital

5. Garud Cancer Hospital

Abstract

Abstract

Purpose The purpose of this study was to compare intravaginal (IVBT) with interstitial brachytherapy (ISBT) in patients presenting with residual or recurrent disease after inadvertent hysterectomy for cervical cancer. Methods Records of consecutive patients with cervical cancer, registered in the Radiotherapy Outpatient Department (RTOPD) between March 2018 and March 2021, who had inadvertent hysterectomy followed by external beam radiotherapy (EBRT) and IVBT (n = 15) or ISBT (n = 15) were analyzed retrospectively. All the patients received a dose of 45Gy-50Gy/25 fractions in 5 weeks by EBRT with concurrent cisplatin. A dose of 6Gy/fraction/week for two consecutive weeks was prescribed at 5mm from the surface of the vaginal cylinder in the IVBT arm. Patients in the ISBT arm were treated with 6Gy/fraction for four fractions over two days with Martinez Interstitial Perineal Template (MUPIT). Overall survival (OS) and disease-free survival (DFS) were the primary endpoints. Acute and late toxicities were the secondary endpoints. Results Median follow-up (FU) was 24.3 months and 32.8 months in the IVBT and ISBT arms respectively. The 3-year OS and DFS for IVBT and ISBT arms were 54% and 93% (p = 0.011) and 42% and 93% (p = 0.023), respectively. Both the arms had similar acute & late toxicities. Conclusion ISBT had significantly better survival outcomes in terms of OS, and DFS with similar toxicity as compared to IVBT in patients with residual or recurrent disease after inadvertent hysterectomy for cervical cancer.

Publisher

Springer Science and Business Media LLC

Reference34 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3